Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Vijaya Diagnostic Centre Ltd. ( (IN:VIJAYA) ) has issued an announcement.
Vijaya Diagnostic Centre has initiated a postal ballot process to seek shareholder approval for the appointment of two independent directors, Mr. Ravi Shankararamiah and Dr. Sasikala Paruchuri Kola. The move underscores the company’s efforts to strengthen its board governance and align with regulatory requirements, using remote e-voting in line with MCA and SEBI guidelines to facilitate wider shareholder participation.
The postal ballot notice and explanatory statement are being circulated electronically to eligible shareholders as of April 3, 2026, with remote e-voting open from April 10 to May 9 and results to be announced by May 12. By leveraging digital voting and complying with updated corporate governance norms, Vijaya Diagnostic Centre signals an emphasis on transparency, regulatory adherence and inclusive decision-making for its investors.
More about Vijaya Diagnostic Centre Ltd.
Vijaya Diagnostic Centre Limited operates in the healthcare diagnostics industry, providing pathology and radiology testing services. The company focuses on serving patients through a network of diagnostic centres, and is listed on both BSE and the National Stock Exchange of India, reflecting its position as an established player in the Indian diagnostics market.
Average Trading Volume: 10,616
Technical Sentiment Signal: Sell
Current Market Cap: 98.87B INR
For detailed information about VIJAYA stock, go to TipRanks’ Stock Analysis page.